Pfizer Inc. buy Guggenheim
Start price
12.03.25
/
50%
€23.60
Target price
12.03.26
-
Performance (%)
-1.14%
End price
13.03.26
€23.33
Summary
This prediction ended on 13.03.26 with a price of €23.33. With a performance of -1.14%, the BUY prediction by Guggenheim finished with a loss. Guggenheim has a follow-up prediction for Pfizer Inc. where he still thinks Pfizer Inc. is a Buy. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pfizer Inc. | 0.533% | 0.533% | 6.371% |
| iShares Core DAX® | 2.591% | 2.691% | 6.411% |
| iShares Nasdaq 100 | -0.915% | -7.368% | 20.651% |
| iShares Nikkei 225® | 0.145% | -10.196% | 46.169% |
| iShares S&P 500 | -0.367% | -0.833% | 18.019% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat
In the thread Trading Pfizer Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten